These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3057361)

  • 1. Problems and prospects in antimutagenesis and anticarcinogenesis.
    De Flora S
    Mutat Res; 1988 Dec; 202(2):279-83. PubMed ID: 3057361
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimutagenesis and anticarcinogenesis mechanisms. Proceedings of the International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. October 6-10, 1985, Lawrence, Kansas. Dedicated to Dr. Charlotte Auerbach and Dr. Takashi Sugimura.
    Basic Life Sci; 1986; 39():1-605. PubMed ID: 3533038
    [No Abstract]   [Full Text] [Related]  

  • 3. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis: a summary.
    Liviero L; von Borstel RC
    Mutat Res; 1996 Feb; 350(1):287-93. PubMed ID: 8657193
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimutagenesis and anticarcinogenesis mechanisms II. Proceedings of the second international conference. December 4-9, 1988, Ohito, Japan.
    Basic Life Sci; 1990; 52():1-485. PubMed ID: 2327937
    [No Abstract]   [Full Text] [Related]  

  • 5. The antievolutionary component of antimutagenesis and anticarcinogenesis: where do mutation rates come from and where are they going?
    Drake JW
    Mutat Res; 1996 Feb; 350(1):5-8. PubMed ID: 8657196
    [No Abstract]   [Full Text] [Related]  

  • 6. New approaches to antimutagenesis.
    Heddle JA; Moody J; Thompson LU; Torous DK; Trentin G
    J Environ Pathol Toxicol Oncol; 1999; 18(2):95-101. PubMed ID: 15281220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of antimutagenesis and anticarcinogenesis: role in primary prevention.
    De Flora S; Izzotti A; Bennicelli C
    Basic Life Sci; 1993; 61():1-16. PubMed ID: 8304921
    [No Abstract]   [Full Text] [Related]  

  • 8. Synopsis of the first International Conference on Antimutagenesis and Anticarcinogenesis: mechanisms.
    Shankel DM; Hartman PE; Kada T; Hollaender A
    Environ Mutagen; 1987; 9(1):87-103. PubMed ID: 3100291
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimutagenesis/anticarcinogenesis 2001: mechanistic studies.
    Gentile JM; Gentile G; Lohman PH; Ferguson LR
    Mutat Res; 2001 Sep; 480-481():1-7. PubMed ID: 11506794
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview.
    De Flora S; Ramel C
    Mutat Res; 1988 Dec; 202(2):285-306. PubMed ID: 3057362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. Banff, Canada, 4-9 September 1994.
    Mutat Res; 1996 Feb; 350(1):1-294. PubMed ID: 8657171
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between human teratogens and carcinogens.
    Miller RW
    J Natl Cancer Inst; 1977 Mar; 58(3):471-4. PubMed ID: 320347
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological actions and interactions of tetrachloroethylene.
    Reichert D
    Mutat Res; 1983 Dec; 123(3):411-29. PubMed ID: 6358882
    [No Abstract]   [Full Text] [Related]  

  • 14. Environmental cancer.
    Weisburger JH
    J Occup Med; 1976 Apr; 18(4):245-52. PubMed ID: 1271127
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings of the International Symposium on Antimutagenesis and Anticarcinogenesis. April 25-26, 2002, Valhalla, New York, USA.
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S1-108. PubMed ID: 12725235
    [No Abstract]   [Full Text] [Related]  

  • 16. Criteria for identifying and classifying carcinogens, mutagens, and teratogens. International Working Party of Experts.
    Regul Toxicol Pharmacol; 1987 Mar; 7(1):1-20. PubMed ID: 3575792
    [No Abstract]   [Full Text] [Related]  

  • 17. Time-dependent mutagenesis and cancer: a new role for antimutagenesis in cancer prevention?
    MacPhee DG
    Mutat Res; 1998 Jun; 402(1-2):29-39. PubMed ID: 9675238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimutagenesis and anticarcinogenesis, from the past to the future.
    Weisburger JH
    Mutat Res; 2001 Sep; 480-481():23-35. PubMed ID: 11506796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation epidemiology: review and recommendations. A report to the International Commission for Protection against Environmental Mutagens and Carcinogens by Committee 5 (Epidemiology).
    Mutat Res; 1983 Sep; 123(1):1-11. PubMed ID: 6888411
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mutagens, teratogens and carcinogens: real and possible hazards].
    Bochkov NP; Bogovskiĭ PA; Napalkov NP
    Vestn Akad Med Nauk SSSR; 1986; (9):18-25. PubMed ID: 3788270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.